- KR₩375bn
- KR₩439bn
- KR₩139bn
- 46
- 29
- 74
- 49
Annual balance sheet for Kinx, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 71,765 | 83,926 | 92,691 | 98,727 | 47,109 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 9,435 | 14,390 | 20,474 | 22,992 | 29,352 |
Prepaid Expenses | |||||
Total Current Assets | 81,466 | 98,532 | 113,462 | 121,934 | 77,216 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 43,145 | 46,116 | 56,579 | 102,706 | 217,582 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 142,751 | 167,211 | 197,438 | 254,807 | 336,793 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 15,657 | 17,246 | 25,746 | 40,037 | 44,566 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Liabilities | 33,472 | 42,465 | 51,798 | 87,270 | 147,545 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 109,279 | 124,746 | 145,640 | 167,537 | 189,248 |
Total Liabilities & Shareholders' Equity | 142,751 | 167,211 | 197,438 | 254,807 | 336,793 |
Total Common Shares Outstanding |